Ipf Clinical Trials
2 recruiting trials for Ipf. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Ipf clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by National Hospital Organization Minami Kyoto Hospital (1), Istanbul Medipol University Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Telerehabilitation exercise program (other, 1 trial), followed by Videobased exercise program.
Track Ipf trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease
We aim to clarify the relationship between sleep hygiene and the onset of sarcopenia or cognitive dysfunction using sleep time, arousal, and sleep quality as indicators in COPD or...
Telerehabilitation in Patients With Idiopathic Pulmonary Fibrosis
It is to determine the effectiveness of different telerehabilitation exercise programs received to 2 groups randomly formed in idiopathic pulmonary fibrosis (IPF) patients. The...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Ipf, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Ipf, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Ipf, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.